Skip to main content

Advertisement

Log in

The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

We aim to evaluate the role of biofilm-producing bacteria in the clinical response to antibiotic therapy among patients affected by chronic bacterial prostatitis (CBP).

Methods

All patients attending our centre from January to December 2008 due to prostatitis-like symptoms with a positive Meares–Stamey test were enroled. The clinical symptoms were assessed according to the NIH-CPSI, and the bacterial strains isolated from the patients enroled were identified and tested for antibiotic sensitivity using cards of the Vitek II semi-automated System for Microbiology (BioMerieux). Quantitative bacterial slime production was assessed by the Christensen microwell assay. All patients were treated with fluoroquinolones for 4 weeks and reevaluated clinically and microbiologically after 3 months.

Results

One hundred and sixteen patients were enroled, and 150 bacterial strains were isolated from all patients. About 85 % of these strains were strong or moderate biofilm producers. Patients with strong or moderate biofilm-producing bacteria had a higher NIH-CPSI symptom score than those without biofilm-producing bacteria (mean 17.6 ± 5.6 vs. 14.1 ± 3.3; p = 0.0009). At the follow-up, 68 patients (58.6 %) had negative microbiological tests, but only 11 (9.48 %) reported a reduction in NIH-CPSI score. Improvement of symptoms was found statistically significantly less frequent in patients with biofilm-producing bacteria than in those without (p = 0.03). Ultrastructural analysis showed cellular forms in active replication with aberrant morphology of unknown cause and confirmed strong slime production with consistent bacterial stratification.

Conclusion

In our CBP population, biofilm-producing bacteria were commonly found and had a significant negative impact on the clinical response to antibiotic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bartoletti R, Cai T, Mondaini N et al (2007) Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multi center case–control observational study. J Urol 178(6):2411–2415

    Article  PubMed  Google Scholar 

  2. Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3):236–237

    Article  CAS  PubMed  Google Scholar 

  3. Drach GW, Fair WR, Meares EM, Stamey TA (1978) Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 120(2):266

    CAS  PubMed  Google Scholar 

  4. Grabe M, Bjerklund-Johansen TE, Botto H et al (2012) Guidelines on urological infections. In: Grabe M, Bjerklund-Johansen TE, Botto H, Wullt B, Çek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F (eds) European Association of Urology Guidelines, ch 10.4.1, p 69

  5. Wagenlehner FM, Naber KG (2003) Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther 1(2):275–282

    Article  PubMed  Google Scholar 

  6. Fulmer BR, Turner TT (2000) A blood-prostate barrier restricts cell and molecular movement across the rat ventral prostate epithelium. J Urol 163(5):1591–1594

    Article  CAS  PubMed  Google Scholar 

  7. Bartoletti R, Cai T (2009) Chronic prostatitis and biofilm. Infez Med 17(1):10–16

    PubMed  Google Scholar 

  8. Kanamaru S, Kurazono H, Terai A, Monden K, Kumon H, Mizunoe Y, Ogawa O, Yamamoto S (2006) Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents 28(1):S21–S25

    Article  CAS  PubMed  Google Scholar 

  9. Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59(3):337–344

    CAS  PubMed  Google Scholar 

  10. Porta M (ed) (2008) A dictionary of epidemiology, 5th edn. Oxford University Press, New York

    Google Scholar 

  11. Giubilei G, Mondaini N, Crisci A et al (2005) The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index. Eur Urol 47(6):805–811

    Article  PubMed  Google Scholar 

  12. Badia X, Garcia-Losa M, Dal-Re R (1997) Ten-language translation and harmonization of the International Prostate Symtom Score: developing a methodology for multinational clinical trials. Eur Urol 31(2):129–140

    CAS  PubMed  Google Scholar 

  13. Christensen GD, Simpson WA, Younger JJ et al (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22(6):996–1006

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE (1992) Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15(1):S216–S227

    Article  PubMed  Google Scholar 

  15. Trinchieri A (2001) Role of levofloxacin in the treatment of urinary tract infections. Arch Ital Urol Androl 73(2):105–113

    Google Scholar 

  16. Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol 162:369

    Article  CAS  PubMed  Google Scholar 

  17. Mazzoli S, Cai T, Rupealta V et al (2007) Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 51(5):1385–1393

    Article  CAS  PubMed  Google Scholar 

  18. Cai T, Wagenlehner FM, Mazzoli S et al (2012) Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent. J Androl 33(4):615–623

    Article  CAS  PubMed  Google Scholar 

  19. Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ (2003) Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 170:818–822

    Article  PubMed  Google Scholar 

  20. Soto SM, Smithson A, Martinez JA et al (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177(1):365–368

    Article  CAS  PubMed  Google Scholar 

  21. Donlan RM, Costerton JW (2002) Biofilm: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Choong S, Whitfield H (2000) Biofilms and their role in infections in urology. BJU Int 86(8):935–941

    Article  CAS  PubMed  Google Scholar 

  23. Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M (2010) The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 10:81

    Article  PubMed Central  PubMed  Google Scholar 

  24. Cai T, Mazzoli S, Meacci F, Boddi V, Mondaini N, Malossini G, Bartoletti R (2011) Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis. J Microbiol 49(3):448–454

    Article  PubMed  Google Scholar 

  25. Bergman B, Wedren H, Holm SE (1989) Staphylococcus saprophyticus in males with symptoms of chronic prostatitis. Urology 34(5):241–245

    Article  CAS  PubMed  Google Scholar 

  26. Murphy AB, Mecejko A, Taylor A, Nadler RB (2009) Chronic prostatitis: management strategies. Drugs 69:71–84

    Article  CAS  PubMed  Google Scholar 

  27. Nickel JC, Olson ME, Barabas A, Benediktsson H, Dasgupta MK, Costerton JW (1990) Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol 66(1):47–54

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to all participating centre’s members for their assistance and to Professor John Denton (Department of Modern Philology, University of Florence) for manuscript language revision.

Conflict of interest

Sanofi-Aventis Italia has provided technical support and funding. No author, however, has financial or commercial conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tommaso Cai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartoletti, R., Cai, T., Nesi, G. et al. The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study. World J Urol 32, 737–742 (2014). https://doi.org/10.1007/s00345-013-1145-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1145-9

Keywords

Navigation